Skip to main content
SpringerLink
Log in

Activated Charcoal in the Treatment of Drug Overdose

An Update

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Albertson TE, Derlet RW, Foulke GE, Inguillon ML, Tharratt SR. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Annals of Emergency Medicine 18: 56–59, 1989

    Article  PubMed  CAS  Google Scholar 

  • Benson B, Van Antwerp M, Hergott T. A fatality resulting from multiple dose activated charcoal therapy. Veterinary and Human Toxicology 31: 335, 1989

    Google Scholar 

  • Berg MJ, Berlinger WG, Goldberg MJ, Spector R, Johnston GF. Acceleration of body clearance of phenobarbital by oral activated charcoal. New England Journal of Medicine 307: 642–644, 1982

    Article  PubMed  CAS  Google Scholar 

  • Berlinger WG, Spector R, Goldberg MJ, Johnson GE, Que CK, et al. Enhancement of theophylline clearance by oral activated charcoal. Clinical Pharmacology and Therapeutics 33: 351–354, 1983

    Article  PubMed  CAS  Google Scholar 

  • Brent J, Kulig K, Rumack BH. Iatrogenic death from sorbitol and magnesium sulfate during treatment for salicylism. Veterinary and Human Toxicology 31: 334, 1989

    Google Scholar 

  • Caldwell JW, Nava AJ, De Haas DD. Hypernatremia associated with cathartics in overdose management. Western Journal of Medicine 147: 593–5 96, 1987

    PubMed  CAS  Google Scholar 

  • Cooney DO. Activated charcoal. Antidotal and other medicinal uses. Marcel Dekker, New York, 1980

    Google Scholar 

  • Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic: prevention of salicylate absorption in a simulated overdose. Archives of Internal Medicine 144: 48–52, 1984

    Article  PubMed  CAS  Google Scholar 

  • Deriet RW, Albertson TE. Activated charcoal — past, present and future. Western Journal of Medicine 145: 493–496, 1986

    Google Scholar 

  • Easom JM, Caraccio TR, Lovejoy Jr FH. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Clinical Pharmacy 1: 154–156, 1982

    PubMed  CAS  Google Scholar 

  • Farley TA. Severe hypernatremic dehydration after use of activated charcoal-sorbitol suspension. Journal of Pediatrics 109: 719–722, 1986

    Article  PubMed  CAS  Google Scholar 

  • Goldberg MJ, Park GD, Spector R, Fischer LJ, Feldman RD. Lack of effect of oral activated charcoal on imipramine clearance. Clinical Pharmacology and Therapeutics 38: 350–353,1985

    Article  PubMed  CAS  Google Scholar 

  • Goldberg MJ, Spector R, Park GD, Roberts RJ. An approach to the management of the poisoned patient. Archives of Internal Medicine 146: 1381–1385, 1986

    Article  PubMed  CAS  Google Scholar 

  • Harsch HH. Aspiration of activated charcoal. New England Journal of Medicine 314: 318, 1986

    PubMed  CAS  Google Scholar 

  • Ho JL, Tierney Mg, Dickinson GE. An evaluation of the effect of repeated doses of activated charcoal on salicylate elimination. Journal of Clinical Pharmacology 29: 366–369, 1989

    PubMed  CAS  Google Scholar 

  • Jones J, Heiselman D, Dougherty J, Eddy E. Cathartic induced magnesium toxicity during overdose management. Annals of Emergency Medicine 15: 1214–1218, 1986

    Article  PubMed  CAS  Google Scholar 

  • Jones J, McMullen MJ, Dougherty J, Cannon L. Repetitive doses of activated charcoal in the treatment of poisoning. American Journal of Emergency Medicine 5: 305–310, 1987

    PubMed  CAS  Google Scholar 

  • Katona BG, Siegel EG, Cluxton Jr RJ. The new black magic: activated charcoal and new therapeutic uses. Journal of Emergency Medicine 5: 9–18, 1987

    Article  PubMed  CAS  Google Scholar 

  • Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Annals of Emergency Medicine 19: 654–656, 1990

    Article  PubMed  CAS  Google Scholar 

  • Kirshenbaum LA, Mathews SC, Sitar DS, Tenenbein M. Does multiple-dose charcoal therapy enhance salicylate excretion? Archives of Interval Medicine 150: 1281–1283, 1990a

    Article  CAS  Google Scholar 

  • Kirshenbaum LA, Sitar DS, Tenenbein M. Interaction between whole bowel irrigation solution and activated charcoal: implications for the treatment of toxic ingestions. Annals of Emergency Medicine 19: 1129–1132, 1990b

    Article  PubMed  CAS  Google Scholar 

  • Krenzelok EP, Keller R, Stewart RD. Gastrointestinal transit times of cathartics combined with charcoal. Annals of Emergency Medicine 14: 1152–1155, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Annals of Emergency Medicine 14: 562–567, 1985

    Article  PubMed  CAS  Google Scholar 

  • Lalonde RL, Deshpande R, Hamilton PP, McLean WM, Greenway DC. Acceleration of digoxin clearance by activated charcoal. Clinical Pharmacology and Therapeutics 37: 367–371, 1985

    Article  PubMed  CAS  Google Scholar 

  • Levy G. Gastrointestinal clearance of drugs with activated charcoal. New England Journal of Medicine 307: 676–678, 1982

    Article  PubMed  CAS  Google Scholar 

  • Levy G, Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Clinical Pharmacology and Therapeutics 13: 317–322, 1972

    PubMed  CAS  Google Scholar 

  • Mauro LS, Mauro VF, Brown DL, Somani P. Enhancement of phenytoin elimination by multiple-dose activated charcoal. Annals of Emergency Medicine 16: 1132–1135, 1987

    Article  PubMed  CAS  Google Scholar 

  • Mayersohn M, Perrier D, Picchioni AL. Evaluation of charcoal mixture as an antidote for oral aspirin overdose. Clinical Toxicology 11: 561–567, 1977

    Article  PubMed  CAS  Google Scholar 

  • McCord MM, Okun AL. Toxicity of sorbitol-charcoal suspension. Journal of Pediatrics 111: 307–308, 1987

    Google Scholar 

  • McNamara R, Aaron CK, Gemborys M, Davidheiser S. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose. Annals of Emergency Medicine 17: 243–246, 1988

    Article  PubMed  CAS  Google Scholar 

  • Menzies DG, Busuttil A, Precott LF. Fatal pulmonary aspiration of activated charcoal. British Medical Journal 297: 459–460, 1988

    Article  PubMed  CAS  Google Scholar 

  • Merigian KS, Woodard M, Hedges Jr, Stuebing R, Rashkin MC. Prospective evaluation of gastric emptying in the self poisoned patient. American Journal of Emergency Medicine 8: 479–483, 1990

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ. Clinical pharmacokinetics or oral activated charcoal in acute intoxications. Clinical Pharmacokinetics 7: 465–489, 1982

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. European Journal of Clinical Pharmacology 17: 51–57, 1980

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Olkkola KT. Effect of purgatives on antidotal efficacy of oral activated charcoal. Human Toxicology 5: 255–263, 1986

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications: role of single and repeated doses. Medical Toxicology 3: 33–58, 1988

    PubMed  CAS  Google Scholar 

  • Park GD, Goldberg MJ, Spector R, Johnson GF, Feldman RD, et al. The effects of activated charcoal on digoxin and digitoxin clearance. Drug Intelligence and Clinical Pharmacy 19: 937–941, 1985

    PubMed  CAS  Google Scholar 

  • Park GD, Spector R, Goldberg MJ, Johnson GF. Expanded role of charcoal therapy in the poisoned and overdosed patient. Archives of Internal Medicine 146: 969–973, 1986

    Article  PubMed  CAS  Google Scholar 

  • Picchioni AL. Activated charcoal: a neglected antidote. Pediatric clinics of North America 17: 535–543, 1870

    Google Scholar 

  • Pond SM. Role of repeated oral doses of activated charcoal in clinical toxicology. Medical Toxicology 1: 341, 1986

    Google Scholar 

  • Pond SM, Olson KR, Osterloh JD, Tong TG. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. Journal of the American Medical Association 251: 3104–3108, 1984

    Article  PubMed  CAS  Google Scholar 

  • Rau NR, Nagaraj MV, Prakash PS, Nelli P. Fatal pulmonary aspiration of activated charcoal. British Medical Journal 297: 918–919, 1988

    Google Scholar 

  • Ray MJ, Padin R., Condie JD, Halls JM. Charcoal bezoar: small bowel obstruction secondary to amitriptyline overdose therapy. Digestive Diseases and Sciences 33: 106–107, 1988

    Article  PubMed  CAS  Google Scholar 

  • Riegel JM, Becker CE. Use of cathartics in toxic ingestions. Annals of Emergency Medicine 10: 254–258, 1981

    Article  PubMed  CAS  Google Scholar 

  • Saetta JP, March S, Gaunt ME, Quinton DN. Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus? Journal of the Royal Society of Medicine 84: 274–276, 1991

    PubMed  CAS  Google Scholar 

  • Saetta JP, Quinton DN. Residual gastric content after gastric lavage and ipecacuanha-induced emesis in self-poisoned patients: An endoscopic study. Journal of the Royal Society of Medicine 84: 35–38, 1991

    PubMed  CAS  Google Scholar 

  • Sessler CN. Poor tolerance of oral activated charcoal with theophylline overdose. American Journal of Emergency Medicine 5: 492–495, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sessler CN. Glauser FL, Cooper KR. Treatment of theophylline toxicity with oral activated charcoal. Chest 87: 325–329, 1985

    Article  PubMed  CAS  Google Scholar 

  • Shannon M, Fish SS, Lovejoy Jr FH. Cathartics and laxatives: do they still have a place in management of the poisoned patient? Medical Toxicology 1: 247–252, 1986

    PubMed  CAS  Google Scholar 

  • Sketris IS, Mowry JB, Czajka PA, Anderson WH, Stafford DT. saline catharsis: effect on aspiration bioavailability in combination with activated charcoal. Journal of Clinical Pharmacology 22: 59–64, 1982

    PubMed  CAS  Google Scholar 

  • Tenenbein M. Inefficacy of gastric emptying procedures. Journal of Emergency Medicine 3: 133–136, 1985

    Article  PubMed  CAS  Google Scholar 

  • Tenenbein M. Whole bowel irrigation in iron poisoning. Journal of Pediatrics 111: 142–145, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tenenbein M. Whole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoning. Medical Toxicology 3: 77–84, 1988

    PubMed  CAS  Google Scholar 

  • Tenenbein M. Multiple doses of activated charcoal — time for reappraisal? Annals of Emergency Medicine 20: 529–531, 1991

    Article  PubMed  CAS  Google Scholar 

  • Tenenbein M, Cohen Sitar DS. Efficacy of ipecac-induced emesis, orogastric lavage and activated charcoal for acute drug overdose. Annals of Emergency Medicine 16: 838–841, 1987

    Article  PubMed  CAS  Google Scholar 

  • Watson WA, Cremer KF, Chapman JA. Gastrointestinal obstruction associated with multiple activated charcoal. Journal of Emergency Medicine 4: 401–407, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine and Department of Pediatrics, Pharmacology, University of Manitoba, and the Manitoba Poison Control Centre, Winnipeg, Manitoba, Canada

    Wesley Palatnick &  Milton Tenenbein

Authors
  1. Wesley Palatnick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milton Tenenbein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palatnick, W., Tenenbein, M. Activated Charcoal in the Treatment of Drug Overdose. Drug-Safety 7, 3–7 (1992). https://doi.org/10.2165/00002018-199207010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199207010-00002

Search

Navigation